|
Dr. Daniel Notterman studies the molecular biology of cancer and is an expert in the field of gene expression. The goals of his laboratory are to better understand the molecular aberrations that drive neoplastic transformation in humans and to develop instrumentation that will aid physicians in diagnosing and monitoring neoplastic disease. Using highly parallel techniques, such as oligonucleotide arrays and cDNA microarrays, Dr. Notterman monitors the expression profiles of thousands of genes in order to identify new cancer pathway genes and to develop a catalogue of genes that are abnormally expressed in colon cancer. In addition to identifying and characterizing individual cancer pathways and genes, he is also supervising a computational approach to tie expression patterns to a new system of classifying cancer. Dr. Notterman received his M.D. from New York University. | 